Folgen
Jeffrey Tosoian
Jeffrey Tosoian
Assistant Professor, Urologic Oncology, Vanderbilt University Medical Center
Bestätigte E-Mail-Adresse bei vumc.org
Titel
Zitiert von
Zitiert von
Jahr
Active surveillance program for prostate cancer: an update of the Johns Hopkins experience
JJ Tosoian, BJ Trock, P Landis, Z Feng, JI Epstein, AW Partin, PC Walsh, ...
J Clin Oncol 29 (16), 2185-2190, 2011
6932011
Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer
JJ Tosoian, M Mamawala, JI Epstein, P Landis, S Wolf, BJ Trock, ...
Journal of Clinical Oncology 33 (30), 3379, 2015
5932015
Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with Gleason score 9 …
AU Kishan, RR Cook, JP Ciezki, AE Ross, MM Pomerantz, PL Nguyen, ...
Jama 319 (9), 896-905, 2018
2992018
Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations
JJ Tosoian, MA Gorin, AE Ross, KJ Pienta, PT Tran, EM Schaeffer
Nature Reviews Urology 14 (1), 15-25, 2017
2642017
Active surveillance for prostate cancer: current evidence and contemporary state of practice
JJ Tosoian, HB Carter, A Lepor, S Loeb
Nature Reviews Urology 13 (4), 205-215, 2016
2372016
Active surveillance of grade group 1 prostate cancer: long-term outcomes from a large prospective cohort
JJ Tosoian, M Mamawala, JI Epstein, P Landis, KJ Macura, ...
European urology 77 (6), 675-682, 2020
1712020
Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance program
JJ Tosoian, S Loeb, A Kettermann, P Landis, DJ Elliot, JI Epstein, ...
The Journal of urology 183 (2), 534-538, 2010
1632010
Association of [− 2] proPSA with biopsy reclassification during active surveillance for prostate cancer
JJ Tosoian, S Loeb, Z Feng, S Isharwal, P Landis, DJ Elliot, R Veltri, ...
The Journal of urology 188 (4), 1131-1136, 2012
1412012
Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis
B Benzon, SG Zhao, MC Haffner, M Takhar, N Erho, K Yousefi, P Hurley, ...
Prostate cancer and prostatic diseases 20 (1), 28-35, 2017
1362017
Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy
MR Chappidi, M Kates, HD Patel, JJ Tosoian, DR Kaye, NA Sopko, ...
Urologic oncology: seminars and original investigations 34 (6), 256. e1-256. e6, 2016
1212016
PSA and beyond: the past, present, and future of investigative biomarkers for prostate cancer
J Tosoian, S Loeb
The Scientific World Journal 10, 1919-1931, 2010
1212010
A systematic review of the evidence for the decipher genomic classifier in prostate cancer
NK Jairath, A Dal Pra, R Vince Jr, RT Dess, WC Jackson, JJ Tosoian, ...
European urology 79 (3), 374-383, 2021
1122021
Pathological outcomes in men with low risk and very low risk prostate cancer: implications on the practice of active surveillance
JJ Tosoian, E JohnBull, BJ Trock, P Landis, JI Epstein, AW Partin, ...
The Journal of urology 190 (4), 1218-1223, 2013
1092013
Prediction of pathological stage based on clinical stage, serum prostate‐specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era
JJ Tosoian, M Chappidi, Z Feng, EB Humphreys, M Han, CP Pavlovich, ...
BJU international 119 (5), 676-683, 2017
1062017
Ability of a genomic classifier to predict metastasis and prostate cancer-specific mortality after radiation or surgery based on needle biopsy specimens
PL Nguyen, Z Haddad, AE Ross, NE Martin, S Deheshi, LLC Lam, ...
European urology 72 (5), 845-852, 2017
1032017
Prostate Health Index density improves detection of clinically significant prostate cancer
JJ Tosoian, SC Druskin, D Andreas, P Mullane, M Chappidi, S Joo, ...
BJU international 120 (6), 793-798, 2017
952017
Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer
SC Druskin, JJ Tosoian, A Young, S Collica, A Srivastava, K Ghabili, ...
BJU international 121 (4), 619-626, 2018
902018
The role of multiparametric magnetic resonance imaging/ultrasound fusion biopsy in active surveillance
TM Ma, JJ Tosoian, EM Schaeffer, P Landis, S Wolf, KJ Macura, JI Epstein, ...
European urology 71 (2), 174-180, 2017
892017
Racial variations in prostate cancer molecular subtypes and androgen receptor signaling reflect anatomic tumor location
FA Faisal, D Sundi, JJ Tosoian, V Choeurng, M Alshalalfa, AE Ross, ...
European urology 70 (1), 14-17, 2016
882016
Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer
HB Kaur, LB Guedes, J Lu, L Maldonado, L Reitz, JR Barber, ...
Modern Pathology 31 (10), 1539-1552, 2018
842018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20